Free Trial

1,749 Shares in Cardinal Health, Inc. (NYSE:CAH) Bought by Childress Capital Advisors LLC

Cardinal Health logo with Medical background

Childress Capital Advisors LLC bought a new position in Cardinal Health, Inc. (NYSE:CAH - Free Report) in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 1,749 shares of the company's stock, valued at approximately $241,000.

A number of other hedge funds have also added to or reduced their stakes in CAH. Ieq Capital LLC increased its holdings in Cardinal Health by 42.5% in the fourth quarter. Ieq Capital LLC now owns 15,477 shares of the company's stock worth $1,830,000 after purchasing an additional 4,614 shares in the last quarter. Handelsbanken Fonder AB grew its stake in Cardinal Health by 11.6% in the fourth quarter. Handelsbanken Fonder AB now owns 39,783 shares of the company's stock valued at $4,705,000 after acquiring an additional 4,140 shares during the period. Transcend Capital Advisors LLC grew its stake in Cardinal Health by 3.6% in the fourth quarter. Transcend Capital Advisors LLC now owns 2,735 shares of the company's stock valued at $323,000 after acquiring an additional 96 shares during the period. Sigma Planning Corp grew its stake in Cardinal Health by 3.6% in the fourth quarter. Sigma Planning Corp now owns 11,844 shares of the company's stock valued at $1,401,000 after acquiring an additional 413 shares during the period. Finally, Fjarde AP Fonden Fourth Swedish National Pension Fund grew its stake in Cardinal Health by 2.1% in the fourth quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 52,517 shares of the company's stock valued at $6,211,000 after acquiring an additional 1,100 shares during the period. 87.17% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

CAH has been the subject of a number of research reports. Wells Fargo & Company raised Cardinal Health from an "equal weight" rating to an "overweight" rating and raised their price objective for the company from $136.00 to $179.00 in a research note on Tuesday, June 3rd. Citigroup reissued a "neutral" rating and issued a $170.00 price objective (up previously from $157.00) on shares of Cardinal Health in a research note on Friday, June 13th. Wall Street Zen raised Cardinal Health from a "buy" rating to a "strong-buy" rating in a research note on Monday, May 5th. Bank of America raised their price objective on Cardinal Health from $165.00 to $170.00 and gave the company a "buy" rating in a research note on Tuesday, June 10th. Finally, Mizuho lifted their target price on Cardinal Health from $142.00 to $150.00 and gave the company an "outperform" rating in a research report on Monday, March 31st. Three equities research analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $157.43.

Get Our Latest Stock Analysis on CAH

Cardinal Health Trading Down 0.3%

Shares of NYSE:CAH traded down $0.44 during mid-day trading on Wednesday, hitting $163.77. 2,693,567 shares of the company traded hands, compared to its average volume of 2,240,226. The stock has a 50-day moving average price of $151.30 and a two-hundred day moving average price of $134.89. The stock has a market cap of $39.09 billion, a P/E ratio of 25.55, a P/E/G ratio of 1.83 and a beta of 0.66. Cardinal Health, Inc. has a 12-month low of $93.17 and a 12-month high of $166.32.

Cardinal Health (NYSE:CAH - Get Free Report) last issued its quarterly earnings results on Thursday, May 1st. The company reported $2.35 EPS for the quarter, topping analysts' consensus estimates of $2.15 by $0.20. The business had revenue of $54.88 billion for the quarter, compared to analyst estimates of $55.33 billion. Cardinal Health had a negative return on equity of 68.84% and a net margin of 0.70%. Cardinal Health's quarterly revenue was up .0% compared to the same quarter last year. During the same period last year, the company posted $2.08 earnings per share. As a group, analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, July 15th. Investors of record on Tuesday, July 1st will be issued a dividend of $0.5107 per share. This is a positive change from Cardinal Health's previous quarterly dividend of $0.51. This represents a $2.04 dividend on an annualized basis and a yield of 1.25%. The ex-dividend date of this dividend is Tuesday, July 1st. Cardinal Health's dividend payout ratio (DPR) is 31.51%.

Cardinal Health Company Profile

(Free Report)

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

Featured Stories

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Should You Invest $1,000 in Cardinal Health Right Now?

Before you consider Cardinal Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.

While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

The Next Palantir? AI-Defense Stock Set for Explosive Growth
2 Chip Stocks Are Soaring—But One Could Break Out This Summer
Congress Bought This Stock at the Bottom—Will You Miss It?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines